Jon J. Van Rood

Jon J. Van Rood's AcademicInfluence.com Rankings

Jon J. Van Rood

Philosophy

#7677

World Rank

#10922

Historical Rank

Logic

#4717

World Rank

#6041

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jon J. Van Rood's Degrees

Doctorate Medicine Leiden University

Why Is Jon J. Van Rood Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jon J. Van Rood's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (2004) (1075)
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. (1996) (616)
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. (1997) (463)
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia (2003) (447)
The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses (2003) (361)
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. (1992) (328)
One million haemopoietic stem-cell transplants: a retrospective observational study. (2015) (316)
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. (2002) (282)
The serological recognition of the human MLC determinants using a modified cytotoxicity technique. (2008) (282)
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. (1988) (262)
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. (2006) (249)
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens (2007) (223)
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. (1989) (219)
Unparalleled complexity of the MHC class I region in rhesus macaques. (2005) (217)
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. (2006) (212)
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase (2001) (199)
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. (1983) (196)
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. (1999) (183)
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. (2008) (179)
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. (1981) (175)
Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft (2006) (174)
Evidence for an ancient selective sweep in the MHC class I gene repertoire of chimpanzees (2002) (157)
Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. (1978) (153)
Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies (2009) (135)
Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. (1979) (130)
Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients (1987) (129)
ABO blood group barrier in allogeneic bone marrow transplantation revisited. (2005) (120)
GENETIC CONTROL OF SURVIVAL IN EPIDEMICS (1979) (107)
HLA gene haplotype frequencies in bone marrow donors worldwide registries. (1997) (103)
The influence of allogeneic cells on the human T and B cell repertoire. (1990) (101)
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex (2001) (97)
Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment. (1993) (89)
HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. (1980) (89)
HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types. (2008) (86)
Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation (2012) (86)
THE EFFECT OF HLA MATCHING ON KIDNEY GRAFT SURVIVAL IN SEPARATE POSTTRANSPLANTATION INTERVALS (1990) (84)
HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism (1986) (83)
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. (2012) (83)
Milestones of Hematopoietic Stem Cell Transplantation – From First Human Studies to Current Developments (2016) (82)
In vitro immune responsiveness to vaccinea virus and HLA. (1977) (80)
HLA-DR-associated genetic control of the type of leprosy in a population from surinam. (1982) (76)
Efficacy of HL-A matching in Eurotransplant. (1972) (76)
HLA-linked control of predisposition to lepromatous leprosy. (1985) (76)
Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells. (1984) (75)
Differential immunogenicity of HLA mismatches in clinical transplantation. (2005) (74)
Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. (1984) (72)
Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identifcal unrelated donor. (1973) (72)
Typing for MLC (LD). I. Lymphocytes from cousin-marriage offspring as typing cells. (1973) (71)
Joint report of 1st International Workshop on Canine Immunogenetics. (1973) (70)
Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiency. (1979) (68)
Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51. (1992) (68)
Both self and non-inherited maternal HLA antigens influence the immune response. (2000) (68)
Bone Marrow Donors Worldwide: a successful exercise in international cooperation. (1994) (67)
HLA-linked genetic control of host response to Mycobacterium leprae. (1976) (66)
A new determinant, defined by PLT, coded for in the HLA region and apparently independent of the HLA-D and DR loci. (2008) (64)
Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development (2007) (64)
EFFECTOR MECHANISMS IN GRAFT‐VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS: II. EVIDENCE OF A POSSIBLE INVOLVEMENT OF PROLIFERATIVE T CELLS (1990) (63)
EFFECTOR MECHANISMS IN GRAFT‐VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS: I. ABSENCE OF CORRELATION WITH CYTOTOXIC EFFECTOR CELLS (1990) (63)
Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors (1979) (63)
Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. (1980) (63)
Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells (1988) (62)
LEUKOCYTE GROUPING. A METHOD AND ITS APPLICATION. (1963) (61)
Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. (1969) (61)
Factors contributing to long-term kidney graft survival in Eurotransplant. (1992) (59)
AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz (2010) (59)
Effect of blood transfusions and HLA matching on renal transplantation in the Netherlands. (1977) (59)
CELL‐MEDIATED LYMPHOLYSIS STUDIES IN RENAL ALLOGRAFT RECIPIENTS (1981) (58)
Historic Landmarks in Clinical Transplantation: Conclusions from the Consensus Conference at the University of California, Los Angeles (2000) (57)
THE IMPORTANCE OF H‐Y INCOMPATIBILITY IN HUMAN ORGAN TRANSPLANTATION (1978) (56)
Mixed lymphocyte cultures and HL-A. (1971) (55)
Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species. (2006) (55)
Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. (1996) (53)
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation (1986) (53)
Analysis of cytotoxic T cell precursor frequencies directed against individual HLA-A and -B alloantigens. (1989) (53)
Influence of breast feeding on the cytotoxic T cell allorepertoire in man. (1991) (53)
Bone marrow donors worldwide. (2020) (51)
Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance (2017) (51)
HLA-DRw6 and renal allograft rejection. (1983) (50)
25th anniversary of the first successful allogeneic bone marrow transplants. (1994) (49)
Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. (1982) (49)
Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. (2005) (49)
A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques (2007) (48)
Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients. (2017) (48)
SEROLOGICAL AND MOLECULAR STUDIES OF EPSTEIN‐BARR VIRUS INFECTION IN ALLOGENEIC MARROW GRAFT RECIPIENTS (1990) (47)
The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. (1995) (47)
Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value. (1989) (46)
NE1: a new neutrophil specific antigen. (2008) (46)
Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches. (1989) (44)
HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML). (2008) (44)
Modulation of the alloimmune response by blood transfusions. (2001) (43)
Defined leukocyte antigens of chimpanzees: use of chimpanzee isoantisera for leukocyte typing in man. (1967) (43)
An HLA-DQ alpha allele identified at DNA and protein level is strongly associated with celiac disease. (1988) (43)
Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones. (1990) (43)
Production, expansion, and clonal analysis of T cells with specific HLA-restricted male lysis. (1980) (42)
Major histocompatibility locus of rhesus monkeys (RhL-A). (1971) (42)
Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants (1982) (42)
Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells (1991) (41)
Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen. (1992) (40)
Validation of haplotype frequency estimation methods. (1998) (40)
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes (2017) (40)
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. (1994) (40)
DR typing in Australian Aborigines. An indication for a second locus in the HLA--D region defined by serology. (2008) (38)
Immunomodulation by blood transfusions. (2000) (38)
Human hematopoietic progenitor cells in long-term cultures express HLA- DR antigens and lack HLA-DQ antigens (1985) (38)
Antibodies against donor antigens on endothelial cells and monocytes in eluates of rejected kidney allografts. (2008) (38)
Relation of insulin-dependent diabetes mellitus (IDD) and the HLA-linked SB system. (2008) (38)
Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population. (2008) (37)
Successful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle. (1973) (37)
IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not. (1994) (37)
Validation of large data sets, an essential prerequisite for data analysis: an analytical survey of the Bone Marrow Donors Worldwide. (1996) (37)
HLA antigen distribution and HLA haplotype segregation in Crohn's disease. (2008) (37)
Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A. (1973) (37)
Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. (1993) (36)
PROGNOSTIC INDICES TO PREDICT SURVIVAL OF FIRST AND SECOND RENAL ALLOGRAFTS (1991) (36)
Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus (2014) (36)
A search for association of HLA antigens with paranoid schizophrenia. A9 appears as a possible marker. (2008) (36)
Distribution of endothelial-monocyte and HLA antigens on renal vascular endothelium. (1981) (35)
The impact of HLA-A matching on long-term survival of renal allografts. (1996) (35)
Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. (1990) (35)
DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLs IN VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506 (1993) (35)
[Pregnancy following kidney transplantation]. (1971) (34)
The relation of parental sex and age to recombination in the HL-A system. (1973) (34)
ANTIBODIES DIRECTED AGAINST ANTIGENS ON THE ENDOTHELIUM OF PERITUBULAR CAPILLARIES IN PATIENTS WITH REJECTING RENAL ALLOGRAFTS (1979) (32)
Two major factors influencing kidney graft survival in Eurotransplant: HLA-DR matching and blood transfusion(s). (1981) (32)
The interaction of drugs and endogeneous substances with HLA class-I antigens. (1985) (32)
Erythrocyte Survival‐Time Determinations with the Aid of DF32P (1961) (32)
HL-A identical phenotypes and genotypes in unrelated individuals. (1970) (31)
Longevity and heredity in humans. Association with the human leucocyte antigen phenotype. (1991) (31)
Lymphocyte transformation in vitro. II. Mixed lymphocyte culture in relation to leucocyte antigens. (1970) (31)
Oligonucleotide typing is a perfect tool to identify antigens stimulatory in the mixed lymphocyte culture. (1991) (30)
High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD. (1993) (30)
Neonatal tolerance revisited. (1989) (30)
Minor histocompatibility antigens, defined by graft‐vs.‐host disease‐derived cytotoxic T lymphocytes, show variable expression on human skin cells (1991) (29)
The effect of noninherited maternal antigens in allogeneic transplantation. (2005) (29)
Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing. (1991) (28)
Cell membrane polymorphisms coded for in the HLA-D/DR region. I. Relation between D and DR. (1982) (28)
Naturally acquired microchimerism (2014) (28)
Anti-thymocyte globulin treatment for aplastic anemia. (2009) (28)
Treatment of aplastic anaemia by antilymphocyte globulin with or without marrow infusion. (1978) (28)
Molecular localization of LB-Q1, a DRw52-like T-cell recognition epitope and identification at the genomic level of associated shared hybridizing fragments. (1987) (27)
Selection of cross-match negative HLA-A and/or -B mismatched donors for highly sensitized patients. (1989) (27)
Two different T-cell systems in humans, one of which is probably equivalent to Qa or Tla in mice. (1985) (27)
Automatic reading and recording of the microlymphocytotoxicity test. (2008) (27)
Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize. (1991) (27)
Blood component therapy in bone marrow transplantation. (1984) (27)
No evidence of an influence of the noninherited maternal HLA antigens on the alloreactive T cell repertoire in healthy individuals. (1995) (27)
A METHOD TO RELATE LEUKOCYTE ANTIGENS AND TRANSPLANTATION ANTIGENS IN MONKEYS (1965) (27)
Influence of possible HL-A haploidentity on renal-graft survival in Eurotransplant. (1974) (26)
Recognition of DP determinants with typing reagents prepared with lymphocytes from Dutch unrelated individuals. (2008) (26)
Interaction of penicillin with HLA-A and -B antigens. (1982) (26)
INFLUENCE OF MATCHING FOR HLA‐DR ANTIGENS ON SKIN GRAFT SURVIVAL (1979) (26)
Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA) on artificial monolayers of platelets. (1981) (25)
An estimation of the recombination fraction between the MLC locus and the FOUR locus. (2008) (25)
HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study. (1984) (25)
Inhibition of the mixed leukocyte reaction by alloantisera in man. II. Incidence and characteristics of MLC-inhibiting antisera from multiparous women. (2008) (25)
Reanalysis of the HLA-DRw6 complex. (2008) (25)
Human histocompatibility antigens in normal and neoplastic tissues. (1968) (25)
The detection of transplantation antigens in leukocytes. (1969) (24)
Differential resistance to paralytic poliomyelitis controlled by histocompatibility leukocyte antigens. (1983) (24)
Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3. (1984) (24)
Allo-antibodies to an antigenic determinant shared by HLA-A2 and B17. (1982) (24)
Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens. (1994) (24)
The role of primary MLC of the non HLA-D/DR determinant PL3A. (2008) (24)
Antibodies to endothelial antigens in eluates of 88 human kidneys: correlation with graft survival and presence of T- and B-cell antibodies. (1981) (24)
The detection of non-HLA antibodies and their possible role in bone marrow graft rejection. (1979) (23)
The locus for glyoxalase i (GLO) is between HLA-A and PGM3 on chromosome 6 of man. (1976) (23)
The influence of inherited and noninherited parental antigens on outcome after transplantation (2006) (23)
On the heterogeneity of linkage estimations between LA and four loci of the HL-A system,. (2008) (23)
IgM-IgG cryoglobulinaemia with IgM paraprotein component. (1968) (23)
LB-Q1 and LB-Q2: two determinants defined in the primed lymphocyte test and independent of HLA-D/DR, MB/LB-E, or SB. (1983) (23)
POLYMORPHISM OF THE DL‐A SYSTEM (1972) (22)
HLA associations with leukemia. (1987) (22)
A molecular mechanism of T cell downregulation by blood transfusion. (1993) (22)
Recognition of distinct epitopes on the HLA-A2 antigen by cytotoxic T lymphocytes. (1986) (22)
The value of the determination of the site of red cell sequestration in hemolytic anemia as a prediction test for splenectomy. (2009) (22)
Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti‐thymocyte globulin (1989) (22)
Mixed-lymphocyte-culture and skin-graft data in unrelated HL-A identical individuals. (1971) (22)
Unambiguous typing for HLA-DQ TA10 and 2B3 specificities using specific oligonucleotide probes. (1989) (22)
Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks. (2014) (22)
Interpretation of data obtained from primed lymphocyte tests (PLTs). (1977) (21)
Role of the HLA system in transplantation. HLA compatibility in clinical transplantation. (1977) (21)
Complexity of stimulation in MLC and the influence of matching for HLA-A and -B. (1981) (21)
The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions. (2000) (21)
A Proposed Algorithm Predictive for Cytotoxic T Cell Alloreactivity (2012) (20)
A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies. (1996) (20)
Hyperimmunized patients do not need to wait for an HLA identical donor. (1989) (20)
Renal transplant patients with steroid withdrawal evaluated longitudinally for their donor--specific cytotoxic T cell reactivity. (1991) (20)
Leukocyte typing and kidney transplantation in unrelated donor-recipient pairs. A study in patients of Drs. S. Peart, J.F.Mowbray, and G.R.J. Alexandre. (1969) (20)
Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys. (1998) (19)
INFLUENCE OF A SINGLE BLOOD TRANSFUSION ON KIDNEY ALLOGRAFT SURVIVAL IN UNRELATED RHESUS MONKEYS (1978) (19)
Analysis of HLA-D micropolymorphism by a simple procedure: RNA oligonucleotide hybridization. (1987) (19)
Clinical experience with bone marrow transplantation: failure and success. (1971) (19)
Tolerance to kidney allograft transplanted into Type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches (1999) (19)
Noninherited maternal HLA antigens: a proposal to elucidate their role in the immune response. (2000) (19)
Relevance of pretransplant donor-specific T cell allorepertoire for human kidney graft survival. (1995) (18)
Permissible mismatches, acceptable mismatches, and tolerance: new trends in decision making. (1993) (18)
Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro. (1989) (18)
Group-specific auto-immune antibodies directed to granulocytes as a cause of chronic benign neutropenia in infants. (1982) (17)
GENETIC ASPECTS OF CANINE MIXED LEUKOCYTE CULTURES (1974) (17)
HLA and sporadic tuberculoid leprosy: a population study in Maharashtra, India. (1981) (17)
Typing for MLC (LD). II. The selection of nonstimulator cells by MLC inhibition tests using SD-indentical stimulator cells (MISIS) and fluorescence antibody studies. (1973) (17)
HLA regulates postrenal transplant CML nonreactivity. (1985) (17)
The role of minor histocompatibility antigens in GVHD and rejection: a mini-review. (1991) (17)
Drug-induced antibodies: interaction of the drug with a polymorphic platelet-antigen. (2008) (17)
Di-allelic alloantigenic systems on subsets of T cells. (1982) (16)
The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors. (1990) (16)
Polymorphic B-cell determinants in man. (1977) (16)
TREATMENT OF THROMBOCYTOPENIC PATIENTS WITH REPEATED PLATELET TRANSFUSIONS. (1965) (16)
HLA associations in Italian and non-Italian Caucasoid aplastic anaemia patients. (2008) (16)
In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. (1996) (16)
Correlations between polymorphisms at the DNA and at the protein level of DRw52 haplotypes, revealed with a variety of techniques. (1988) (16)
The regulatory role of HLA-DRw6 in renal transplantation. (2008) (16)
Automated reading of Propidium Iodide lymphocytotoxicity tests for HLA-DR, MB, MT typing. (1984) (16)
IDENTIFICATION OF CHIMPANZEE LEUKOCYTE ANTIGENS (ChL‐A) AND THEIR RELATION TO HL‐A (1971) (16)
Eurotransplant experience with highly immunized patients. (1985) (15)
Leukocyte antigens of rhesus monkeys (RhL-A) and chimpanzees (ChL-A): similarities with the human HL-A system. (2008) (15)
HL-A and ChL-A: similarities and differences. (1972) (15)
The T-cell repertoire is not dictated by self antigens alone. (1991) (15)
A new strategy to improve kidney graft survival: the induction of CML nonresponsiveness. (1979) (15)
Blind confirmation in Leiden of Geczy factor on the cells of Dutch patients with ankylosing spondylitis. (1986) (15)
LEUKOAGGLUTINATING ISOANTIBODIES IN RHESUS MONKEYS (1965) (14)
Cell-mediated lysis of human hematopoietic progenitor cells. (1987) (14)
The quest for a bone marrow donor--optimal or maximal HLA matching? (1998) (14)
TCA: a polymorphic genetic marker in leukemias and melanoma cell lines. (1986) (14)
Leukocytes antigens of chimpanzees and their relation to human HL-A antigens. (1970) (14)
Mixed lymphocyte culture and HL-A. (1972) (14)
A reassessment of the HL-A system in Khoisan populations of South West Africa. (1975) (14)
Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. (1993) (13)
Can anti HLA-A and -B antibodies inhibit the MLC test? (1978) (13)
All monocyte antigens are not expressed on renal endothelium. (2008) (13)
Influence of ultraviolet radiation treatment on the survival of heterotopic skin grafts in the mouse. (1985) (13)
A special strategy to increase the chance of finding cross-match negative kidneys for highly sensitized patients. (1988) (13)
INFLUENCE OF PREVIOUS IMMUNIZATION ON SKIN GRAFT SURVIVAL (1979) (13)
No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals. (2005) (13)
Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome. (2014) (13)
The influence of HLA-A2 subtype mismatch on renal allograft survival. (1992) (13)
The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988. (1988) (13)
Analysis of variability in lymphocyte transformation tests. (1983) (12)
The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation. (1978) (12)
Ninth International Histocompatibility pre-workshop testing of Dw6 HTCs. Two subtypes of Dw6. (2008) (12)
Kidney transplantation - transplant survival after planned HLA-A and -B matched blood transfusions. (2008) (12)
The impact of center variation on the HLA-DR matching effect in kidney graft survival. (1989) (12)
Lymphokine-activated killer cell functions in patients with leukemic B-lymphoproliferative diseases. (1989) (12)
When selecting an HLA mismatched stem cell donor consider donor immune status. (2009) (12)
HLA-linked lymphocyte activating determinants. (1982) (12)
HLA A, B, DR and endothelial-specific antigens in kidney-graft rejection. (1980) (12)
Immunological investigations in aplastic anemia patients. (1984) (12)
Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell. (1990) (12)
PURIFICATION OF LEUKOCYTE GROUP SUBSTANCES FROM HUMAN PLACENTAL TISSUE (1964) (11)
Prospects in host-donor matching. (1971) (11)
CONSEQUENT INTRAFAMILIAL IMMUNIZATION FOR DL-A HAPLOTYPING IN CANINES (1973) (11)
Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications. (1996) (10)
Two alloantigens on human monocytes: a diallelic system? (1987) (9)
Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for the mononuclear cells of AS patients. (1988) (9)
HLA-DR beta III and HLA-DP induce comparable proliferation in primary mixed lymphocyte culture. (1988) (9)
Bone marrow donors worldwide (BMDW). (1991) (9)
HL-A antigens and breast cancer. (1974) (9)
Time trend in annual kidney graft survival. (1988) (9)
Joint report of first histocompatibility workshop on primates. (1972) (8)
B-cell colony growth of malignant and normal B-cells. (1987) (8)
Determining the extent of maternal-foetal chimerism in cord blood (2019) (8)
HLA and I. (1993) (8)
Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys. (1998) (8)
HLA-linked control of the course of M. leprae infections. (1981) (7)
Applicability of HLA-DQB oligonucleotide typing for the TA10 and 2B3 specificities in routine HLA typing. (1990) (7)
Leukocyte antigens of chimpanzees (ChL-A). (1972) (7)
Experimental skin grafting in man. (1979) (7)
Subtypes of HLA-A1 defined on the basis of CTL precursor frequencies. (1990) (7)
Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation. (1989) (7)
EVIDENCE THAT THE DIFFERENCE IN KIDNEY GRAFT SURVIVAL IN DRw6+ AND DRw6− RECIPIENTS MAY BE EXPLAINED BY A BLOOD TRANSFUSION POLICY THAT IS DISADVANTAGEOUS FOR DRw6+ RECIPIENTS (1987) (7)
The influence of a partially HLA-matched blood transfusion on the disease activity of rheumatoid arthritis. (1999) (7)
Heterologous antisera for human histocompatibility testing. (1971) (7)
Anti HL-A2 Inhibitor in Normal Human Serum (1970) (7)
Molecular identification of the TCA alloantigen as the transferrin receptor on T-cells of a leukemic patient with serum from a monozygotic twin brother. (1983) (7)
Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. (2013) (6)
Comparison of complement-dependent cytotoxicity and indirect immunofluorescence for enumeration of T-cell subpopulations in human peripheral blood. (1983) (6)
Occurrence of posttransplant donor-specific cell-mediated lympholysis nonreactivity in renal allograft recipients with perioperative transfusions only. (1985) (6)
The hyperimmunized patient: from sensitization toward transplantation. (1988) (6)
Recognition of polymorphic monocyte antigens. (2008) (6)
Acquired aplastic anaemia in adults. I. A retrospective analysis of 40 cases: single factors influencing the prognosis. (1977) (5)
Inhibition of the mixed leukocyte reaction by alloantisera in man. I. Technical aspects. (2008) (5)
The interaction between gamma-type endorphins and HLA class I antigens. (1986) (5)
Identity of PL3A and SB1. (2008) (5)
The impact of the HLA-system in clinical medicine. (1993) (5)
Blood transfusion and second kidney allograft survival. (1981) (5)
Influence of graft‐versus‐host disease prophylaxis on early T‐lymphocyte regeneration following allogeneic bone marrow transplantation (1986) (5)
Linkage disequilibrium in HLA cannot be explained by selective recombination. (1995) (5)
Functional properties of anti-B-cell antigen alloantisera. (1977) (5)
Comparison of techniques for the detection of monocyte specific antigens. (1985) (5)
Immunobiology of HLA class-I and class-II molecules. Introduction. (1985) (5)
BENEFICIAL EFFECT OF HLA‐A AND B MATCHED PRETRANSPLANT BLOOD TRANSFUSIONS ON PRIMARY CADAVERIC KIDNEY GRAFT SURVIVAL (1983) (5)
A study of genetic markers in families with a recombination in the HL-A region. (1975) (5)
Human alloimmune sera against T cell subsets. Detection and influence on pokeweed mitogen-stimulated Ig production in vitro. (1980) (5)
Comparison of the humoral and cytotoxic T-lymphocyte response to individual HLA class I alloantigens in highly immunized patients. (1991) (5)
The outcome of cell mediated lympholysis is influenced by the antibiotics in the culture medium. (1982) (5)
Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft. (1996) (4)
The unrelated bone marrow donor. (1988) (4)
Cyclosporine A, hyperimmunized patients, and renal retransplantation. (1987) (4)
Different biology and pathology of minor alloantigen-specific cytotoxic and proliferative T cells. (1991) (4)
An HLA matched donor! An HLA matched donor? What do you mean by: HLA matched donor? (1998) (4)
The importance of leukocyte antigens in renal transplantation. (1968) (4)
Platelet and granulocyte specific allo-antigens in chimpanzees. (2008) (4)
LD-SD interaction in vivo and the allograft reaction. (1973) (4)
Organ sharing based on HLA matching saves dialysis years and patient lives. (1993) (4)
HLA and duodenal ulcer in The Netherlands. (2008) (4)
Significant factors influencing kidney graft survival. (1981) (3)
Neutrophil-specific antigen NE1 is not the antithetical allele of ND1. (1981) (3)
Weighing optimal graft survival through HLA matching against the equitable distribution of kidney allografts. (2004) (3)
Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy. (1989) (3)
Successful bone marrow transplantation for aplastic anemia using a HLA phenotypically identical parent. (1981) (3)
Immunological consequences of blood transfusions. (1991) (3)
Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness (2018) (3)
Nomenclature for Factors of the HLA System 1977 (1977) (3)
Transplantation in hyperimmunized patients. (1989) (3)
Renal allograft and patient survival in combined pancreas/kidney transplantation. (1989) (3)
Antigenic composition of human renal vascular endothelium assessed by kidney perfusion. (2008) (3)
HC restricted dual specific inhibition of mixed leukocyte culture reactions by human HLA antibody molecules. (2008) (3)
Typing for the MLC determinants and its possible impact on Europdonor. (1974) (3)
A microabsorption assay to determine acceptable HLA-A and B mismatches for highly immunized patients. (1989) (3)
Blood transfusions and kidney transplantation. (1976) (3)
The role of HLA typing in clinical kidney transplants: 30 years later HLA matching is prime importance in bone marrow transplantation. (1993) (3)
Cytotoxic T lymphocytes directed against HLA-Bw 35-linked target determinants show differences in sensitivity toward antibiotics during sensitization period. (1982) (3)
Human leucocyte antigen phenotypes and gold-induced remissions in patients with rheumatoid arthritis. (1995) (3)
The Leiden "class IV" or "class I-like" workshop November 20-23, 1986. (1988) (3)
Leucocyte migration test in human renal allograft. (1974) (3)
The micro-complement-fixation test. 3. Automatic quantitative scoring with a microscope densitometer. (2008) (3)
The influence of HLA-DRw6 on donor-recipient selection in kidney transplantation. (1985) (3)
Relationship between kidney graft prognosis and HL-A typing using a microabsorption technique. (1971) (2)
Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group. (1981) (2)
A new sensitive assay for the detection of HLA antigens on human epithelial cells. (1984) (2)
The HLA linkage group. (1976) (2)
Platelet supportive care: immunological and clinical aspects. (1979) (2)
Incidence of anti-host cytotoxic and proliferative T cell responses after HLA-identical bone marrow transplantation (BMT). (1989) (2)
On the nature of leucocyte iso-antigens from human placental tissue. (1965) (2)
The effect of antithymocyte globulin on abnormal lymphocyte transformation in patients with aplastic anemia. (1979) (2)
Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA). Comparative studies with the indirect immunofluorescence assay. (1981) (2)
The contribution of failure time of first kidney graft to predicting failure of regrafts. (1990) (2)
Cadaveric graft survival, clinical course, blood transfusion, HLA (A and B) match, and DR match in adult patients transplanted in one centre. (1979) (2)
The role of the computer in a histocompatibility laboratory. (2008) (2)
[Leukocyte groups]. (1962) (2)
How can HLA matching improve kidney graft survival? (1979) (2)
[Immunologic HLA-typing. A tool for selection of recipients in transplantation and for detection of disposition to certain diseases (author's transl)]. (1977) (2)
Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors. (1993) (2)
Soluble HLA antigens and their peptides as immunoregulators and monitoring devices. (1999) (2)
Major and minor histocompatibility systems in man and their importance in bone marrow transplantation. (1976) (2)
[Kidney transplantation (experiences from Leiden)]. (1968) (2)
Major histocompatibility complex or HL-A antibodies in patients with a rejection reaction [proceedings]. (1977) (2)
The effect of HLA-matching, cyclosporin-A, and transplant year on annual kidney graft survival. (1989) (2)
Half a century of Dutch transplant immunology. (2014) (2)
Genetics of two human monocyte antigens. (1988) (2)
On the clinical importance of privileged sites. (2002) (2)
Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine. (1992) (2)
The Leiden B cell workshop May 5-8 1976. (1976) (2)
Eurotransplant. Part II. The cyclosporine era 1981-1985. (1986) (1)
HLA antigens as carrier molecules. (1986) (1)
Genetic basis of gluten-sentitive enteropathy. (1978) (1)
9a: risk factor in bone marrow transplantation? (1988) (1)
[DURATION OF THROMBOCYTE SURVIVAL AND THROMOCYTE TRANSFUSION]. (1963) (1)
CML nonreactivity after kidney transplantation. (1981) (1)
Women, pregnancy and serendipity: a personal story about the discovery of HLA. (2004) (1)
[Migration inhibition test in clinical use. II. Detection inhibition of allograft rejection in kidney transplantation]. (1973) (1)
A study on genetic markers in families with a recombination in the HL-A region. (1975) (1)
HLA as regulator. (1984) (1)
Monolayer absorption of human cytotoxic T cells: evidence for clonality. (2008) (1)
Double Role of HLA in Organ Transplantation (2000) (1)
What can we learn from Bone Marrow Donors Worldwide (BMDW). (1992) (1)
MEASUREMENT OF RAT ANTIBODIES USING A HAEMAGGLUTINATING AUTOANALYZER: A Preliminary Report of the Method (1972) (1)
Analysis of the donor-specific cytotoxic T-cell repertoire in a patient with a long-term surviving kidney allograft. (1990) (1)
HUMAN SKIN GRAFTS FROM MIXED LYMPHOCYTE CULTURE‐POSITIVE DONORS PROVIDE HELP FOR THE RAPID REJECTION OF SIMULTANEOUSLY TRANSPLANTED SKIN GRAFTS FROM MIXED LYMPHOCYTE CULTURE‐NEGATIVE DONORS (1979) (1)
Kidney graft survival, clinical course, and HLA-A, B, and D matching in 208 patients transplanted in one center. (1979) (1)
[Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells]. (1989) (1)
Match prognostic index for predicting waiting time to renal transplantation. (1993) (1)
Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8. (1981) (1)
[Possibilities of the use of Cr-51 in the determination of the length of survival of thrombocytes]. (1963) (1)
The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation – a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR (2018) (1)
The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect. (1987) (1)
HLA and infectious diseases. (1982) (1)
[Not Available]. (1957) (0)
Jon van Rood, FRCP: Senior Consultant Europdonor Foundation. (2016) (0)
[The identification of transplantation antigens in leukocytes]. (1969) (0)
[Antigens against leukocytes in the serum of pregnant women]. (1959) (0)
Plasmapheresis treatment of haemorrhagic complications in a patient with multiple myeloma. (1967) (0)
[The HLA system; a functional approach]. (1982) (0)
[Tissue typing--basis for clinical organ transplantation]. (1971) (0)
HLA and the rubella-specific immune response following vaccination. (1984) (0)
The Niels Jerne lecture. Why does the exposure to allogeneic cells sometimes lead to immunization and sometimes not? (1990) (0)
The importance of non-HLA sytems and the feasibility of the use of unrelated donors in bone marrow transplantation [proceedings]. (1978) (0)
Letter: HL-A 27 and ankylosing spondylitis. (1975) (0)
[Research with the aid of radioactive chromium on hemolytic anemia patients]. (1961) (0)
Prognostic indices for first and second transplants can predict kidney graft survival. (1991) (0)
[Transfusion problems in extracorporeal circulation]. (1961) (0)
The impact of transplantation on immunogenetics (or the importance of a single chance observation and of close international cooperation in unraveling the genetics of HLA). (1980) (0)
Soluble HLA antigens: how it all started. (1999) (0)
Laboratory procedures used to select an unrelated HLA matched bone marrow donor. (1993) (0)
HLA and infectious diseases. (1979) (0)
The impact of the HLA system in clinical hematology. (1989) (0)
The role of different histocompatibility testing methods for selection of related and unrelated bone marrow donors. (1994) (0)
Nomenclature for factors of the HLA system 1984. (1985) (0)
The impact of cyclosporine A on the DRw6 effect in renal transplantation. (1987) (0)
Histocompatibility testing in man. (1977) (0)
1996 Medawar Prize Lecture--looking back and forward. (1997) (0)
Workshop on the fundamentals of histocompatibility antigens. (1973) (0)
Matched or mismatched? That is the question. (1987) (0)
[HLA-compatibility testing in kidney transplantation--past, present and future]. (1980) (0)
Determining the extent of maternal-foetal chimerism in cord blood (2019) (0)
Two patients with a lympho-epithelial tumor and cryoglobulins. (1966) (0)
[Safety of blood transfusions; need for 'hemo-vigilance']. (1998) (0)
Nomenclature for factors of the HLA system-1977. (1978) (0)
The search for standard HLA reagents. (1976) (0)
The prognosis of aplastic anaemia (AA) and the indication for bone marrow transplantation [proceedings]. (1978) (0)
Factors affecting the long-term outcome following non-living kidney transplantation. (1992) (0)
[The determination of erythrocyte survival with the aid of DFP-32]. (1960) (0)
[Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia]. (1978) (0)
Improved kidney graft survival in Eurotransplant by HLA-DR matching and prospectively given blood transfusions. (1981) (0)
The locus for glyoxalase I (GLO) is between HLA-A and PGM3 on chromosome 6 of man. (1976) (0)
[Enzyme deficiencies in 2 patients with non-spherocytic hemolytic anemia]. (1962) (0)
[Life span and physiological behavior of the platelets]. (1959) (0)
[Significance of leukocytotic antigens in kidney transplantation]. (1968) (0)
[Stress and immunity: the importance of multidisciplinary research]. (1986) (0)

This paper list is powered by the following services:

Jon J. Van Rood's Academic­Influence.com Rankings

Jon J. Van Rood's Degrees

Why Is Jon J. Van Rood Influential?

Jon J. Van Rood's Published Works

Published Works

Jon J. Van Rood's AcademicInfluence.com Rankings